Stock Analysis on Net
AI Tokens
Stock Analysis on Net

Cytokinetics Inc. (NASDAQ:CYTK)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Total Asset Turnover
since 2005

Microsoft Excel

Calculation

Cytokinetics Inc., total asset turnover, long-term trends, calculation

Microsoft Excel
Total asset turnover = Revenues1 ÷ Total assets1
Dec 31, 2022 0.09 = 94,588 ÷ 1,014,775
Dec 31, 2021 0.08 = 70,428 ÷ 841,319
Dec 31, 2020 0.10 = 55,828 ÷ 533,803
Dec 31, 2019 0.09 = 26,868 ÷ 289,814
Dec 31, 2018 0.15 = 31,501 ÷ 211,178
Dec 31, 2017 0.05 = 13,368 ÷ 294,810
Dec 31, 2016 0.63 = 106,407 ÷ 170,142
Dec 31, 2015 0.25 = 28,658 ÷ 115,237
Dec 31, 2014 0.35 = 46,940 ÷ 132,968
Dec 31, 2013 0.37 = 30,648 ÷ 83,188
Dec 31, 2012 0.10 = 7,559 ÷ 77,551
Dec 31, 2011 0.08 = 4,000 ÷ 52,773
Dec 31, 2010 0.03 = 2,577 ÷ 77,992
Dec 31, 2009 0.67 = 81,538 ÷ 122,599
Dec 31, 2008 0.14 = 12,420 ÷ 87,454
Dec 31, 2007 0.09 = 13,622 ÷ 155,370
Dec 31, 2006 0.02 = 3,127 ÷ 169,516
Dec 31, 2005 0.10 = 8,912 ÷ 91,461

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands

The total asset turnover ratio for the period between 2005 and 2022 demonstrates significant volatility, characterized by sporadic peaks and prolonged intervals of low asset utilization efficiency.

Asset Turnover Volatility
The ratio has fluctuated drastically, reaching notable peaks of 0.67 in 2009 and 0.63 in 2016. These spikes correlate with substantial increases in annual revenue, which reached 81.5 million USD and 106.4 million USD respectively, while the asset base remained relatively contained. Conversely, the ratio experienced severe troughs, falling to 0.02 in 2006 and 0.03 in 2010, indicating periods where revenue generation was minimal relative to the total assets held.
Revenue Dynamics and Efficiency
A pattern of inconsistent revenue streams is observable, where sharp increases are frequently followed by steep declines. For instance, the efficiency peak of 0.63 in 2016 was immediately followed by a drop to 0.05 in 2017, as revenue fell from 106.4 million USD to 13.4 million USD. This suggests that revenue generation is driven by irregular events rather than steady, scalable operational growth.
Impact of Asset Base Expansion
A significant shift occurred between 2017 and 2022, during which total assets grew aggressively from 294.8 million USD to 1.01 billion USD. Although revenues increased to 94.6 million USD by 2022, the expansion of the asset base far outpaced revenue growth. This disparity resulted in a stabilization of the total asset turnover ratio at a low level, ranging between 0.08 and 0.10 from 2019 through 2022, reflecting a diminished capacity to generate sales from the increasing investment in assets.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Comparison to Competitors

Cytokinetics Inc., total asset turnover, long-term trends, comparison to competitors

Microsoft Excel
Cytokinetics Inc. AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Vertex Pharmaceuticals Inc.
Dec 31, 2022 0.09 0.42 0.38 0.48 0.37 0.58 0.43 0.51 0.54 0.51 0.42 0.46 0.49
Dec 31, 2021 0.08 0.38 0.40 0.42 0.35 0.58 0.40 0.52 0.46 0.45 0.63 0.41 0.56
Dec 31, 2020 0.10 0.30 0.39 0.36 0.29 0.53 0.36 0.47 0.52 0.28 0.50 0.47 0.53
Dec 31, 2019 0.09 0.37 0.37 0.20 0.29 0.57 0.36 0.52 0.55 0.31 0.53 0.44 0.50
Dec 31, 2018 0.15 0.55 0.34 0.64 0.42 0.56 0.34 0.53 0.51 0.34 0.57 0.43 0.49
Dec 31, 2017 0.05 0.40 0.27 0.62 0.39 0.51 0.37 0.49 0.46 0.31 0.67 0.37 0.70
Dec 31, 2016 0.63 0.39 0.28 0.58 0.37 0.55 0.53 0.51 0.42 0.31 0.70 0.40 0.59
Dec 31, 2015 0.25 0.43 0.29 0.52 0.43 0.56 0.62 0.53 0.39 0.29 0.73 0.41 0.41
Dec 31, 2014 0.35 0.72 0.28 0.47 0.54 0.53 0.71 0.57 0.43 0.29 0.73 0.39 0.25
Dec 31, 2013 0.37 0.64 0.28 0.42 0.55 0.66 0.48 0.54 0.42 0.30 0.71 0.41 0.52
Dec 31, 2012 0.10 0.68 0.31 0.49 0.55 0.66 0.44 0.55 0.45 0.32 0.66 0.46 0.55
Dec 31, 2011 0.08 — 0.31 0.64 0.54 0.72 0.47 0.57 0.46 0.36 0.34 0.44 0.64
Dec 31, 2010 0.03 — 0.34 0.63 0.59 0.74 0.64 0.60 0.43 0.35 0.42 0.51 0.08
Dec 31, 2009 0.67 — 0.36 0.61 0.57 0.80 0.67 0.65 0.24 0.23 0.51 0.47 0.05
Dec 31, 2008 0.14 — 0.40 0.70 0.73 0.70 0.72 0.75 0.51 0.43 0.36 0.50 0.18
Dec 31, 2007 0.09 — 0.41 0.74 0.63 0.70 0.64 0.75 0.50 0.42 0.13 0.46 0.33
Dec 31, 2006 0.02 — 0.41 0.70 0.75 0.71 0.63 0.76 0.51 0.42 0.11 0.18 0.23
Dec 31, 2005 0.10 — 0.41 0.68 0.87 0.60 0.48 0.87 0.49 0.44 0.16 0.62 0.29

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Cytokinetics Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Cytokinetics Inc. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2022 0.09 0.47
Dec 31, 2021 0.08 0.45
Dec 31, 2020 0.10 0.39
Dec 31, 2019 0.09 0.39
Dec 31, 2018 0.15 0.45
Dec 31, 2017 0.05 0.40
Dec 31, 2016 0.63 0.41
Dec 31, 2015 0.25 0.42
Dec 31, 2014 0.35 0.44
Dec 31, 2013 0.37 0.43
Dec 31, 2012 0.10 0.45
Dec 31, 2011 0.08 0.47
Dec 31, 2010 0.03 0.47
Dec 31, 2009 0.67 0.39
Dec 31, 2008 0.14 0.57
Dec 31, 2007 0.09 0.56
Dec 31, 2006 0.02 0.54
Dec 31, 2005 0.10 0.57

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Cytokinetics Inc., total asset turnover, long-term trends, comparison to industry (health care)

Microsoft Excel
Cytokinetics Inc. Health Care
Dec 31, 2022 0.09 0.66
Dec 31, 2021 0.08 0.62
Dec 31, 2020 0.10 0.57
Dec 31, 2019 0.09 0.57
Dec 31, 2018 0.15 0.63
Dec 31, 2017 0.05 0.56
Dec 31, 2016 0.63 0.57
Dec 31, 2015 0.25 0.55
Dec 31, 2014 0.35 0.60
Dec 31, 2013 0.37 0.58
Dec 31, 2012 0.10 0.58
Dec 31, 2011 0.08 0.61
Dec 31, 2010 0.03 0.61
Dec 31, 2009 0.67 0.55
Dec 31, 2008 0.14 0.73
Dec 31, 2007 0.09 0.71
Dec 31, 2006 0.02 0.69
Dec 31, 2005 0.10 0.66

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).